TABLE 1.
Characteristics | Patient no. (%) |
||||
Total (n = 998) | FMDP (n = 129) | PMDP (n = 530) | MetSP (n = 339) | P-value | |
Grade | 0.780 | ||||
G1 and 2 | 826 (82.8) | 104 (80.6) | 440 (83.0) | 282 (83.2) | |
G3 and 4 | 172 (17.2) | 25 (19.4) | 90 (17.0) | 57 (16.8) | |
Age group | 0.087 | ||||
Age < 50 | 256 (25.7) | 43 (33.3) | 134 (25.3) | 79 (23.3) | |
Age > = 50 | 742 (74.3) | 86 (66.7) | 396 (74.7) | 260 (76.7) | |
Family history | 0.089 | ||||
No | 842 (84.4) | 117 (90.7) | 440 (83.0) | 285 (84.1) | |
Yes | 156 (15.6) | 12 (9.3) | 90 (17.0) | 54 (15.9) | |
Lymph-vascular space invasion (LVSI) | 0.333 | ||||
No | 930 (93.2) | 118 (91.5) | 491 (92.6) | 321 (94.7) | |
Yes | 68 (6.8) | 11 (8.5) | 39 (7.4) | 18 (5.3) |
Values of p are based on the chi-square test among three groups in the clinical characteristics. MetSP, patients with metabolic syndrome; PMDP, patients with partial metabolic abnormality; FMDP, patients with free metabolic disorder.